Literature DB >> 12460253

Cerebral activation during vagus nerve stimulation: a functional MR study.

Jaishree T Narayanan1, Richard Watts, Naim Haddad, Douglas R Labar, P Mark Li, Christopher G Filippi.   

Abstract

PURPOSE: To study the short-term effects of vagus nerve stimulation (VNS) on brain activation and cerebral blood flow by using functional magnetic resonance imaging (fMRI).
METHODS: Five patients (three women, two men; mean age, 35.4 years) who were treated for medically refractory epilepsy with VNS, underwent fMRI. All patients had a nonfocal brain MRI. The VNS was set at 30 Hz, 0.5-2.0 mA for intervals of activation of 30 s on and 30 s off, during which the fMRI was performed. Statistical parametric mapping (SPM) was used to determine significant areas of activation or inhibition during vagal nerve stimulation (p < 0.05).
RESULTS: VNS-induced activation was detected in the thalami bilaterally (left more than right), insular cortices bilaterally, ipsilateral basal ganglia and postcentral gyri, right posterior superior temporal gyrus, and inferomedial occipital gyri (left more than right). The most robust activation was seen in the thalami (left more than right) and insular cortices.
CONCLUSIONS: VNS-induced thalamic and insular cortical activation during fMRI suggests that these areas may play a role in modulating cerebral cortical activity, and the observed decrease in seizure frequency in patients who are given VNS may be a consequence of this increased activation.

Entities:  

Mesh:

Year:  2002        PMID: 12460253     DOI: 10.1046/j.1528-1157.2002.16102.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  31 in total

1.  "Pusher syndrome" following cortical lesions that spare the thalamus.

Authors:  Leif Johannsen; Doris Broetz; Thomas Naegele; Hans-Otto Karnath
Journal:  J Neurol       Date:  2006-02-03       Impact factor: 4.849

Review 2.  Therapeutic effects of vagus nerve stimulation in epilepsy and implications for sudden unexpected death in epilepsy.

Authors:  Steven C Schachter
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

3.  BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation.

Authors:  T Kraus; K Hösl; O Kiess; A Schanze; J Kornhuber; C Forster
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

4.  Interoception, homeostatic emotions and sympathovagal balance.

Authors:  Irina A Strigo; Arthur D Bud Craig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-10-10       Impact factor: 6.237

Review 5.  Interoceptive contributions to healthy eating and obesity.

Authors:  W Kyle Simmons; Danielle C DeVille
Journal:  Curr Opin Psychol       Date:  2017-07-08

6.  A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder.

Authors:  Yiheng Tu; Jiliang Fang; Jin Cao; Zengjian Wang; Joel Park; Kristen Jorgenson; Courtney Lang; Jun Liu; Guolei Zhang; Yanping Zhao; Bing Zhu; Peijing Rong; Jian Kong
Journal:  Brain Stimul       Date:  2018-01-31       Impact factor: 8.955

7.  Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial.

Authors:  Chen Shi; Steven R Flanagan; Uzma Samadani
Journal:  Neurol Res       Date:  2013-04       Impact factor: 2.448

Review 8.  Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

Authors:  Paul J Carlson; Jaskaran B Singh; Carlos A Zarate; Wayne C Drevets; Husseini K Manji
Journal:  NeuroRx       Date:  2006-01

Review 9.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  Perfusion imaging in Pusher syndrome to investigate the neural substrates involved in controlling upright body position.

Authors:  Luca Francesco Ticini; Uwe Klose; Thomas Nägele; Hans-Otto Karnath
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.